International Biotechnology Trust’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

International Biotechnology Trust’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-341,468	Closed	-$8.32M	–	74
2017 Q4	$8.32M	Hold	341,468	–	–	2.94%	12
2017 Q3	$6.3M	Hold	341,468	–	–	2.45%	12
2017 Q2	$5.66M	Hold	341,468	–	–	2.15%	10
2017 Q1	$4.7M	Sell	341,468 -61,852	-15%	-$993K	1.8%	15
2016 Q4	$7.63M	Buy	+403,320	New	+$7.74M	3.44%	12

International Biotechnology Trust's ENTL Position: Q1 2018 in Review

International Biotechnology Trust sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 341,468 shares — an estimated $8.32M sold.

International Biotechnology Trust first reported a position in ENTL in Q4 2016 and held it in 5 quarters. The position peaked at $8.32M in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

International Biotechnology Trust reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
International Biotechnology Trust sold 341,468 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $8.32M.
International Biotechnology Trust first reported a position in Entellus Medical, Inc. Common Stock in Q4 2016 and held it in 5 quarters.
International Biotechnology Trust's Entellus Medical, Inc. Common Stock position peaked at $8.32M in Q4 2017.
0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on International Biotechnology Trust's 13F filing for Q1 2018, filed 15 May 2018.